120 related articles for article (PubMed ID: 21137059)
1. Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver.
Liao YJ; Chen KH; Huang SF; Chen TL; Wang CK; Chien CH; Tsai TF; Liu SP; Chen YM
Proteomics Clin Appl; 2010 Apr; 4(4):394-406. PubMed ID: 21137059
[TBL] [Abstract][Full Text] [Related]
2. Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway.
Chen SY; Lin JR; Darbha R; Lin P; Liu TY; Chen YM
Cancer Res; 2004 May; 64(10):3617-23. PubMed ID: 15150120
[TBL] [Abstract][Full Text] [Related]
3. Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect.
Yen CH; Hung JH; Ueng YF; Liu SP; Chen SY; Liu HH; Chou TY; Tsai TF; Darbha R; Hsieh LL; Chen YM
Toxicol Appl Pharmacol; 2009 Mar; 235(3):296-304. PubMed ID: 19146867
[TBL] [Abstract][Full Text] [Related]
4. Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver.
Liu SP; Li YS; Chen YJ; Chiang EP; Li AF; Lee YH; Tsai TF; Hsiao M; Huang SF; Chen YM
Hepatology; 2007 Nov; 46(5):1413-25. PubMed ID: 17937387
[TBL] [Abstract][Full Text] [Related]
5. Higher susceptibility to aflatoxin B(1)-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice.
Liu SP; Li YS; Lee CM; Yen CH; Liao YJ; Huang SF; Chien CH; Chen YM
Int J Cancer; 2011 Feb; 128(3):511-23. PubMed ID: 20473876
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.
Liao YJ; Liu SP; Lee CM; Yen CH; Chuang PC; Chen CY; Tsai TF; Huang SF; Lee YH; Chen YM
Int J Cancer; 2009 Feb; 124(4):816-26. PubMed ID: 19035462
[TBL] [Abstract][Full Text] [Related]
7. Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Liao YJ; Lee TS; Twu YC; Hsu SM; Yang CP; Wang CK; Liang YC; Chen YA
J Biomed Sci; 2016 Oct; 23(1):69. PubMed ID: 27716281
[TBL] [Abstract][Full Text] [Related]
8. Benzo[a]pyrene and glycine N-methyltransferse interactions: gene expression profiles of the liver detoxification pathway.
Lee CM; Chen SY; Lee YC; Huang CY; Chen YM
Toxicol Appl Pharmacol; 2006 Jul; 214(2):126-35. PubMed ID: 16545412
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments.
Yang CP; Wang HA; Tsai TH; Fan A; Hsu CL; Chen CJ; Hong CJ; Chen YM
Eur Neuropsychopharmacol; 2012 Aug; 22(8):596-606. PubMed ID: 22264868
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic differences between two Gnmt-/- mouse models for hepatocellular carcinoma.
Chen YM; Liao YJ; Liu SP; Tsai TF
Hepatology; 2009 Jun; 49(6):2130-1; author reply 2131. PubMed ID: 19475685
[No Abstract] [Full Text] [Related]
11. Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma.
Kant R; Yen CH; Lu CK; Lin YC; Li JH; Chen YM
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153064
[TBL] [Abstract][Full Text] [Related]
12. Identification of FKBP11 as a biomarker for hepatocellular carcinoma.
Lin IY; Yen CH; Liao YJ; Lin SE; Ma HP; Chan YJ; Chen YM
Anticancer Res; 2013 Jun; 33(6):2763-9. PubMed ID: 23749938
[TBL] [Abstract][Full Text] [Related]
13. Benzo[a]pyrene effects on glycine N-methyltransferase mRNA expression and enzyme activity in Fundulus heteroclitus embryos.
Fang X; Dong W; Thornton C; Willett KL
Aquat Toxicol; 2010 Jun; 98(2):130-8. PubMed ID: 20185185
[TBL] [Abstract][Full Text] [Related]
14. Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis.
Liao YJ; Chen TL; Lee TS; Wang HA; Wang CK; Liao LY; Liu RS; Huang SF; Chen YM
Mol Med; 2012 May; 18(1):412-22. PubMed ID: 22183894
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma.
Chen M; Yang MH; Chang MM; Tyan YC; Chen YA
Toxicol Appl Pharmacol; 2019 Sep; 378():114607. PubMed ID: 31170416
[TBL] [Abstract][Full Text] [Related]
16. Benzo(a)pyrene induced glycine N-methyltransferase messenger RNA expression in Fundulus heteroclitus embryos.
Fang X; Dong W; Thornton C; Scheffler B; Willett KL
Mar Environ Res; 2010; 69 Suppl():S74-6. PubMed ID: 19892394
[TBL] [Abstract][Full Text] [Related]
17. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
Martínez-Chantar ML; Vázquez-Chantada M; Ariz U; Martínez N; Varela M; Luka Z; Capdevila A; Rodríguez J; Aransay AM; Matthiesen R; Yang H; Calvisi DF; Esteller M; Fraga M; Lu SC; Wagner C; Mato JM
Hepatology; 2008 Apr; 47(4):1191-9. PubMed ID: 18318442
[TBL] [Abstract][Full Text] [Related]
18. Targeted and untargeted metabolomics provide insight into the consequences of glycine-N-methyltransferase deficiency including the novel finding of defective immune function.
Eudy BJ; McDermott CE; Liu X; da Silva RP
Physiol Rep; 2020 Sep; 8(18):e14576. PubMed ID: 32951289
[TBL] [Abstract][Full Text] [Related]
19. A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme.
Luka Z; Capdevila A; Mato JM; Wagner C
Transgenic Res; 2006 Jun; 15(3):393-7. PubMed ID: 16779654
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in GNMT-/- mice.
Wagner C; Luka Z; Mato JM
Toxicol Appl Pharmacol; 2009 Jun; 237(2):246; author reply 247. PubMed ID: 19345238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
